505 related articles for article (PubMed ID: 17682002)
1. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
Kugathasan S; Saubermann LJ; Smith L; Kou D; Itoh J; Binion DG; Levine AD; Blumberg RS; Fiocchi C
Gut; 2007 Dec; 56(12):1696-705. PubMed ID: 17682002
[TBL] [Abstract][Full Text] [Related]
2. Cytokine gene expression in intestinal tuberculosis and Crohn's disease.
Pugazhendhi S; Jayakanthan K; Pulimood AB; Ramakrishna BS
Int J Tuberc Lung Dis; 2013 May; 17(5):662-8. PubMed ID: 23575333
[TBL] [Abstract][Full Text] [Related]
3. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.
Plevy SE; Landers CJ; Prehn J; Carramanzana NM; Deem RL; Shealy D; Targan SR
J Immunol; 1997 Dec; 159(12):6276-82. PubMed ID: 9550432
[TBL] [Abstract][Full Text] [Related]
4. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.
Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M
Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.
Neurath MF; Weigmann B; Finotto S; Glickman J; Nieuwenhuis E; Iijima H; Mizoguchi A; Mizoguchi E; Mudter J; Galle PR; Bhan A; Autschbach F; Sullivan BM; Szabo SJ; Glimcher LH; Blumberg RS
J Exp Med; 2002 May; 195(9):1129-43. PubMed ID: 11994418
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.
Breese E; Braegger CP; Corrigan CJ; Walker-Smith JA; MacDonald TT
Immunology; 1993 Jan; 78(1):127-31. PubMed ID: 8436398
[TBL] [Abstract][Full Text] [Related]
7. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
8. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease.
Morimoto K; Hosomi S; Yamagami H; Watanabe K; Kamata N; Sogawa M; Machida H; Okazaki H; Tanigawa T; Nagahara H; Noda E; Tominaga K; Watanabe T; Fujiwara Y; Maeda K; Hirakawa K; Arakawa T
Scand J Gastroenterol; 2011 Jun; 46(6):701-9. PubMed ID: 21463244
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.
Rovedatti L; Kudo T; Biancheri P; Sarra M; Knowles CH; Rampton DS; Corazza GR; Monteleone G; Di Sabatino A; Macdonald TT
Gut; 2009 Dec; 58(12):1629-36. PubMed ID: 19740775
[TBL] [Abstract][Full Text] [Related]
11. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.
Matsuoka K; Inoue N; Sato T; Okamoto S; Hisamatsu T; Kishi Y; Sakuraba A; Hitotsumatsu O; Ogata H; Koganei K; Fukushima T; Kanai T; Watanabe M; Ishii H; Hibi T
Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590
[TBL] [Abstract][Full Text] [Related]
12. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls.
Hart AL; Kamm MA; Knight SC; Stagg AJ
Clin Exp Immunol; 2004 Jan; 135(1):137-45. PubMed ID: 14678275
[TBL] [Abstract][Full Text] [Related]
14. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S
Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820
[TBL] [Abstract][Full Text] [Related]
15. Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease.
Matsuura T; West GA; Levine AD; Fiocchi C
Dig Liver Dis; 2000; 32(6):484-94. PubMed ID: 11057923
[TBL] [Abstract][Full Text] [Related]
16. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.
Veny M; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
Aliment Pharmacol Ther; 2010 Mar; 31(5):561-72. PubMed ID: 19958311
[TBL] [Abstract][Full Text] [Related]
17. [Colonic expression of gamma-interferon and interleukin-10 in Crohn's disease and ulcerative colitis].
Kallel L; Boubaker J; Louzir H; Ben Ahmed M; Sassi A; Boubaker S; Zouari B; Filali A
Presse Med; 2005 Jan; 34(1):8-12. PubMed ID: 15685091
[TBL] [Abstract][Full Text] [Related]
18. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
[TBL] [Abstract][Full Text] [Related]
19. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response?
Oki M; Ohtani H; Kinouchi Y; Sato E; Nakamura S; Matsumoto T; Nagura H; Yoshie O; Shimosegawa T
Lab Invest; 2005 Jan; 85(1):137-45. PubMed ID: 15492753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
